QualityStocks Stock Newsletters Archives - Page 761 of 1818

TuesdayApr 28, 2009 5:32 am

ANTs Software, Inc. (ANTSE.OB) Subsidiary Secures $800 Thousand in New Business

ANTs Software Inc. announced that its wholly-owned subsidiary, Inventa Technologies, Inc. closed $800,000 in contracts that is expected to be fully recognized in the current fiscal year. According to the press release, this 2009 incremental revenue is directly related to three projects that will soon be initiated. These projects include: a capacity planning and infrastructure management project for a Fortune 500 Financial Services firm; implementation of infrastructure management tools and processes for a Fortune 500 Insurance Company; and a capacity planning project of hundreds of servers for a major Healthcare Insurance Company “We are very satisfied with the execution and…

TuesdayApr 28, 2009 5:25 am

CleanTech Biofuels, Inc. (CLTH.OB) Demonstrates Capability of Technology; Converts Garbage into Energy

CleanTech Biofuels, Inc., an early stage provider of cellulosic biomass derived from municipal solid waste for energy production, announced today that it has successfully demonstrated the operational capability of its technology that processes municipal solid waste into clean, homogeneous biomass for energy production. Approximately 10 tons of garbage obtained from the City of Chicago was processed. “The successful operation of this vessel is the first step in constructing a commercial plant using clean biomass derived from garbage as a feedstock for energy production,” stated Edward Hennessey, CEO of CleanTech Biofuels. “In reaching this milestone, we have proven the viability of…

TuesdayApr 28, 2009 5:18 am

Genta Inc. (GNTA.OB) To Be Granted Two Key European Patents for Genasense®

Genta Incorporated announced that the European Patent Office intends to grant two key patents related to the company’s intellectual property position on Genasense® (oblimersen sodium) Injection. These two patents will provide protection for compositions, sequences, and pharmaceutical uses of Genasense and related compounds that attack Bcl-2, the molecular target of Genasense action. “Genta’s patent estate related to Genasense is extensive, we have detailed plans for securing rapid approval in Europe with positive data this Fall,” commented Dr. Raymond P. Warrell, Jr., Genta’s Chief Executive Officer. “The majority of patients enrolled into the AGENDA trial, a Phase 3 trial of Genasense…

MondayApr 27, 2009 10:20 am

PURE Bioscience (PURE) Well Positioned to Immediately Respond to Swine Flu Emergency

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to global health challenges. The company's proprietary high efficacy/low toxicity bioscience technologies lead today's global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. PURE Bioscience makes silver dihydrogen citrate-based (SDC) antimicrobials. Patented SDC is an electrolytically-generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from its competitors by its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE Bioscience announced today that its…

MondayApr 27, 2009 10:01 am

ValCom, Inc.’s (VLCO.OB) Subsidiary to Launch Live Interactive Game Show

ValCom, Inc.’s wholly-owned subsidiary, MyFamilyTV, announced earlier today that it will be the exclusive broadcast network to carry "Trivia Live," a live interactive game show, in partnership with Play TV USA LLC. Andy Ford, CEO of Play TV, stated, "This is undoubtedly a very important first step for our entry into the USA TV market, and we are delighted to be working with The MyFamilyTV Network to bring them and their audience, fun, fair and compelling live interactive trivia shows. I'm thrilled to be working with such a fast growing company such as ValCom." MyFamilyTV Executive VP for Programming, Mark…

MondayApr 27, 2009 9:57 am

Peninsula Bank Holding Co. (PBKH.OB) Subsidiary Announces First Quarter Results for 2009

The Private Bank of the Peninsula, a subsidiary of Peninsula Bank Holding Co. (PBKH.OB), announced this afternoon its unaudited financial results for the first quarter of this year. Compared to the same quarter in the previous year, assets increased 30%, loans increased 43%, and deposits increased 26%. Net income for the first quarter totaled $342,000, up 11.4% from the same period in 2008. "We are very pleased to report a profit for the first quarter which can be attributed to some of the initiatives we implemented over the past year," commented Mark D. Mordell, Chairman of the Board. "However, the…

MondayApr 27, 2009 9:45 am

Arrayit Corp. (ARYC.OB) Announces Release of Research Report Establishing $6.49 Price Target

Arrayit Corporation announced today that a 16-page positive research report on the company has been published by one of the nation's leading micro-cap research firms, Grass-Roots-Research. The report can be viewed on the research firm’s website at www.grass-roots-distribution.com The report stated, "We believe that the Company's plan to enter into the molecular diagnostics segment presents a substantial growth opportunity. Arrayit is a potentially lucrative opportunity for risk adverse investors." Grass-Roots-Research established a base case target price of $6.49, which is considerably higher than today's market price of $1.45 per share. Let us hear your thoughts below:

MondayApr 27, 2009 7:15 am

PolyMedix Inc. (PYMX.OB) Prepares for Trials in the Second Quarter 2009

With pharmaceutical products beginning to go off patent, smaller research firms addressing more common viruses and physical maladies are becoming more attractive opportunities for larger pharmaceutical and biotechnology companies. PolyMedix Inc., a development stage biotechnology company, works to develop products oriented toward life threatening acute disorders. Additionally, the company develops products that may hold substantial consumer oriented potential. As many larger pharmaceutical and biotechnology companies’ product pipe-lines are in need of replenishment, the company has the potential to become very profitable with its consumer oriented product line. It does develop products that hold great promise for life threatening disorders, but…

MondayApr 27, 2009 3:50 am

Axial Vector Energy Corp. (AXVC.PK) and Petro-AVEC Forms New Joint Venture

Axial Vector Energy Corporation announced over the weekend that it has formed a Joint Venture involving Petro-AVEC (the previously announced Joint Venture between AVEC and Petrosonics, LLC) and Constellation Capital Management, LLC of Novato, California. This Joint Venture will be named Petro-AVEC North America, LLC ("PANA"). PANA intends to establish its North America headquarters in Northern California immediately. According to the press release, Constellation Capital Management, LLC will own 15% of the JV and Petro-AVEC will own 85%. Petro-AVEC also announced that Constellation Capital’s Senior Advisor William Jeffrey Gilliam has been appointed as PANA's Chief Executive Officer. Commenting on his…

FridayApr 24, 2009 9:15 am

OriginOil, Inc. (OOIL.OB) Leads the Way in Algae-to-Oil Technology

OriginOil, Inc. (OOIL.OB) Leads the Way in Algae to Oil Technology OriginOil Incorporated is developing a breakthrough technology that will transform algae into a true competitor to petroleum. Algae is one of the most promising future sources of renewable oil. Much of the world's oil and gas deposits came from ancient algae deposits. On April 20, 2009, OriginOil announced an innovative single-step process to extract oil from algae. In addition to integrating this process into its own production system, the company plans to rapidly commercialize the patent-pending process for use by others in the rapidly-growing algae industry. Initial testing indicates…

Site Search

Company Search

Category: QualityStocks Stock Newsletters